Amedisys Q2 EPS $1.32 Beats $1.18 Estimate, Sales $591.19M Beat $578.82M Estimate

Author: Benzinga Newsdesk | July 24, 2024 04:57pm
Amedisys (NASDAQ:AMED) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.18 by 11.86 percent. This is a 3.65 percent decrease over earnings of $1.37 per share from the same period last year. The company reported quarterly sales of $591.19 million which beat the analyst consensus estimate of $578.82 million by 2.14 percent. This is a 6.91 percent increase over sales of $552.97 million the same period last year.

Posted In: AMED